首页> 外国专利> Amide derivative, process for preparing an amide derivative, or a pharmaceutically acceptable salt or cleavable ester in vivo thereof, pharmaceutical composition and use of an amide derivative, or a pharmaceutically acceptable salt or cleavable ester in vivo thereof

Amide derivative, process for preparing an amide derivative, or a pharmaceutically acceptable salt or cleavable ester in vivo thereof, pharmaceutical composition and use of an amide derivative, or a pharmaceutically acceptable salt or cleavable ester in vivo thereof

机译:酰胺衍生物,其体内制备酰胺衍生物或其药学上可接受的盐或可裂解的酯的方法,其药物组合物和酰胺衍生物或其药学上可接受的盐或可裂解的酯在体内的用途

摘要

"STARCH DERIVATIVE, PROCESS TO PREPARE A STARCH DERIVATIVE, OR A PHARMACEUTICALLY ACCEPTABLE SALT OR IS CLIVABLE IN VIVO OF THE SAME, PHARMACEUTICAL COMPOSITION AND USE OF A STARCH DERIVATIVE, OR A PHARMACEUTICALLY AFFORDABLE SALT." The invention relates to amide derivatives of formula (I), wherein: G is N or CH; R¹ is a group such as hydroxy, halo, trifluoromethyl, C ~ 1-6 ~ alkyl and C ~ 1-6 ~ alkoxy; each of R² and R³ is hydrogen, halo, C ~ 1-6 ~ alkyl, C ~ 2-6 ~ alkenyl or C ~ 2-6 ~ alkynyl; R ^ 4 ^ is a group such as hydrogen, hydroxy, C ~ 1-6 ~ alkyl, C ~ 1-6 ~ alkoxy and C ~ 3-7 ~ cycloalkyl, or R ^ 4 ^ is of the formula (IC): - KJ, where J is aryl, heteroaryl or heterocyclyl and K is a bond or a group such as oxide and imino, R5 is a group such as hydrogen, halo and trifluoromethyl; m is 1 to 3 and q is 0 to 4; or their pharmaceutically acceptable in vivo cleavable salts or esters; to processes for their preparation, to pharmaceutical compositions containing them and to their use in the treatment of diseases or medical conditions mediated by cytokines.
机译:“淀粉衍生物,制备淀粉衍生物的过程或可药用的盐,或者可在淀粉衍生物,相同的药物成分和使用或淀粉衍生物或药学上可负担的盐的体内使用。”本发明涉及式(I)的酰胺衍生物,其中:G为N或CH; R 1为羟基,卤素,三氟甲基,C 1至6 6烷基和C 1至6 6烷氧基的基团; R 2和R 3分别是氢,卤素,C〜1-6〜烷基,C〜2-6〜链烯基或C〜2-6〜炔基。 R ^ 4 ^是氢,羟基,C〜1-6〜烷基,C〜1-6〜烷氧基和C〜3-7〜环烷基的基团,或R ^ 4 ^具有式(IC): -KJ,其中J是芳基,杂芳基或杂环基,并且K是键或基团,例如氧化物和亚氨基,R 5是基团,例如氢,卤素和三氟甲基; m为1至3,q为0至4;或其药学上可接受的体内可裂解的盐或酯;它们的制备方法,包含它们的药物组合物以及它们在治疗由细胞因子介导的疾病或医学状况中的用途。

著录项

  • 公开/公告号BR9914162A

    专利类型

  • 公开/公告日2001-06-26

    原文格式PDF

  • 申请/专利权人 ASTRAZENECA AB;

    申请/专利号BR19999914162

  • 发明设计人 JOHN GRAHAM CUMMING;

    申请日1999-09-27

  • 分类号C07D239/94;C07D401/12;A61K31/517;

  • 国家 BR

  • 入库时间 2022-08-22 01:25:53

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号